Green Cross Labcell rises 5.02% amid increasing interest in cord blood theme
On the 16th, the umbilical cord blood theme rose by 5.88% compared to the previous day, showing a strong performance, while Green Cross LabCell, a related stock attracting attention, surged by 5.02% compared to the previous day. Green Cross LabCell is known as a cell therapy research and development company.
[Graph] Price Fluctuations of Major Stocks in the Umbilical Cord Blood Theme
According to the analysis by Thinkpool Robo Algorithm RASSI, Green Cross LabCell ranked 2nd out of 7 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Green Cross LabCell having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.
[Table] Top Stocks by Financial Scores within the Theme
※ The quant financial scores are the results of the robo algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
